(Q36384467)

13 August 2017

1 reference

title

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis (English)

1 reference

13 August 2017

1

Megan Cully

1 reference

13 August 2017

Han You

2

1 reference

13 August 2017

Arnold J Levine

series ordinal

3

1 reference

13 August 2017

Tak W Mak

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

13 August 2017

Nature Reviews Cancer

1 reference

13 August 2017

6

1 reference

13 August 2017

184-192

1 reference

13 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1819

13 August 2017

0 references

cites work

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

PTEN: one gene, many syndromes

31 March 2020

1 reference

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

31 March 2020

1 reference

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

31 March 2020

1 reference

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

31 March 2020

1 reference

Dysregulated PTEN-PKB and negative receptor status in human breast cancer

31 March 2020

1 reference

A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities

31 March 2020

1 reference

Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta

31 March 2020

1 reference

Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis

31 March 2020

1 reference

Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis

31 March 2020

1 reference

Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer

31 March 2020

1 reference

PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest

31 March 2020

1 reference

PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization

31 March 2020

1 reference

FoxOs at the crossroads of cellular metabolism, differentiation, and transformation

31 March 2020

1 reference

A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR.

31 March 2020

1 reference

Transcriptional feedback control of insulin receptor by dFOXO/FOXO1.

31 March 2020

1 reference

TSC2: filling the GAP in the mTOR signaling pathway

31 March 2020

1 reference

Upstream and downstream of mTOR

31 March 2020

1 reference

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery

31 March 2020

1 reference

GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR

31 March 2020

1 reference

Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

31 March 2020

1 reference

Signaling from Akt to FRAP/TOR targets both 4E-BP and S6K in Drosophila melanogaster

31 March 2020

1 reference

Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase

31 March 2020

1 reference

Drosophila S6 kinase: a regulator of cell size.

31 March 2020

1 reference

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

31 March 2020

1 reference

Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control

31 March 2020

1 reference

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

31 March 2020

1 reference

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

31 March 2020

1 reference

Multiple roles of the tuberous sclerosis complex genes

31 March 2020

1 reference

Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer

31 March 2020

1 reference

Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma

31 March 2020

1 reference

Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer

31 March 2020

1 reference

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice

31 March 2020

1 reference

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

31 March 2020

1 reference

Does the ribosome translate cancer?

31 March 2020

1 reference

Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis

31 March 2020

1 reference

Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis

31 March 2020

1 reference

The NF1 tumor suppressor critically regulates TSC2 and mTOR.

31 March 2020

1 reference

Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor

31 March 2020

1 reference

Tsc2 is not a critical target of Akt during normal Drosophila development

31 March 2020

1 reference

Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression

31 March 2020

1 reference

Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2

31 March 2020

1 reference

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

31 March 2020

1 reference

PTEN expression causes feedback upregulation of insulin receptor substrate 2

31 March 2020

1 reference

The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins

31 March 2020

1 reference

MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632

31 March 2020

1 reference

Assembly of Cell Regulatory Systems Through Protein Interaction Domains

31 March 2020

1 reference

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

31 March 2020

1 reference

Phosphatidylinositol-3-OH kinase as a direct target of Ras

31 March 2020

1 reference

PTEN: life as a tumor suppressor

31 March 2020

1 reference

Targeting RAS signalling pathways in cancer therapy

31 March 2020

1 reference

Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression

31 March 2020

1 reference

Critical role for Gab2 in transformation by BCR/ABL

31 March 2020

1 reference

Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation.

31 March 2020

1 reference

RNA interference: from gene silencing to gene-specific therapeutics

31 March 2020

1 reference

Regulation of PTEN transcription by p53

31 March 2020

1 reference

The coordinate regulation of the p53 and mTOR pathways in cells

31 March 2020

1 reference

TSC2 mediates cellular energy response to control cell growth and survival

31 March 2020

1 reference

p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas

31 March 2020

1 reference

p53, the cellular gatekeeper for growth and division

31 March 2020

1 reference

31 March 2020

Surfing the p53 network

1 reference

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

31 March 2020

1 reference

BRAFE600-associated senescence-like cell cycle arrest of human naevi

31 March 2020

1 reference

Tumour biology: senescence in premalignant tumours

31 March 2020

1 reference

Oncogene-induced senescence as an initial barrier in lymphoma development.

31 March 2020

1 reference

p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1

31 March 2020

1 reference

Crosstalk between p53 and FOXO transcription factors

31 March 2020

1 reference

Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage

31 March 2020

1 reference

DJ-1, a novel regulator of the tumor suppressor PTEN.

31 March 2020

1 reference

Selecting patients for epidermal growth factor receptor inhibitor treatment: A FISH story or a tale of mutations?

31 March 2020

1 reference

Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer.

31 March 2020

1 reference

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.

31 March 2020

1 reference

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials.

31 March 2020

1 reference

Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.

31 March 2020

1 reference

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

31 March 2020

1 reference

Insulin signaling in health and disease

31 March 2020

1 reference

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

31 March 2020

1 reference

SH2 domains recognize specific phosphopeptide sequences

31 March 2020

1 reference

Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide

31 March 2020

1 reference

Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems

31 March 2020

1 reference

Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins

31 March 2020

1 reference

Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit

31 March 2020

1 reference

Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)

31 March 2020

1 reference

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

31 March 2020

1 reference

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

31 March 2020

1 reference

Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1

31 March 2020

1 reference

Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.

31 March 2020

1 reference

Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice

31 March 2020

1 reference

Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse

31 March 2020

1 reference

Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice

31 March 2020

1 reference

Genetic interactions between Pten and p53 in radiation-induced lymphoma development

31 March 2020

1 reference

PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms

31 March 2020

1 reference

Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation.

31 March 2020

1 reference

DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice

31 March 2020

1 reference

grb2 heterozygosity rescues embryonic lethality but not tumorigenesis in pten+/- mice

31 March 2020

1 reference

Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1819

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference